Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026)

Kiniksa Pharmaceuticals International (KNSA) posted Prepaid Assets of $29.7 million for Q1 2026, down 30.27% on a QoQ basis from $42.6 million in Q4 2025, and up 16.83% year-over-year from $25.4 million in Q1 2025.

Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026) Analysis & Trends

Kiniksa Pharmaceuticals International's Prepaid Assets history runs 10 years deep, the most recent figure standing at $29.7 million for Q1 2026.

  • Quarterly Prepaid Assets rose 16.83% year-over-year to $29.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.7 million (up 16.83% YoY) and the FY2025 annual result came in at $42.6 million, up 112.18% from the prior year.
  • Prepaid Assets was $29.7 million for Q1 2026 at Kiniksa Pharmaceuticals International, down from $42.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $42.6 million in Q4 2025 and bottomed at $10.5 million in Q1 2022.
  • A 5-year average of $22.1 million and a median of $20.1 million in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2023 — Prepaid Assets fell 11.18% — and 2024, when it soared 116.67%.
  • Kiniksa Pharmaceuticals International's Prepaid Assets stood at $10.5 million in 2022, then jumped by 66.44% to $17.5 million in 2023, then increased by 14.52% to $20.1 million in 2024, then soared by 112.18% to $42.6 million in 2025, then plunged by 30.27% to $29.7 million in 2026.
  • Business Quant data shows KNSA's Prepaid Assets at $29.7 million in Q1 2026, $42.6 million in Q4 2025, and $30.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Kiniksa Pharmaceuticals International 4.82 Bn 4.36 Bn 193.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.71 Mn
Dec 31, 2025 42.61 Mn
Sep 30, 2025 30.29 Mn
Jun 30, 2025 32.44 Mn
Mar 31, 2025 25.43 Mn
Dec 31, 2024 20.08 Mn
Sep 30, 2024 33.95 Mn
Jun 30, 2024 26.95 Mn
Mar 31, 2024 13.77 Mn
Dec 31, 2023 17.54 Mn
Sep 30, 2023 26.40 Mn
Jun 30, 2023 12.44 Mn
Mar 31, 2023 13.16 Mn
Dec 31, 2022 10.54 Mn
Sep 30, 2022 15.31 Mn
Jun 30, 2022 14.01 Mn
Mar 31, 2022 10.52 Mn
Dec 31, 2021 6.59 Mn
Sep 30, 2021 8.50 Mn
Jun 30, 2021 9.80 Mn